Adial Pharmaceuticals, Inc.
ADIL
$6.45
-$0.20-3.01%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -2,553.61% | 9.26% | 3.60% | 18.16% | 20.30% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 0.00% | -200.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 20,663.49% | -13.57% | -11.70% | 2.28% | -47.47% |
| Change in Net Operating Assets | -5,250.75% | -50.69% | 38.45% | -194.90% | 88.33% |
| Cash from Operations | -263.66% | -1.70% | 8.89% | -8.22% | 18.56% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -83.96% | 523.12% | -- | -85.47% | 1,188.83% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 375.78% | 523.12% | -- | -85.47% | 1,188.83% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 579.91% | 6.33% | 187.69% | -168.29% | 304.29% |